Woodline Partners’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.4M | Buy |
1,658,663
+934
| +0.1% | +$8.69K | 0.08% | 342 |
|
|
2025
Q1 | $11.2M | Buy |
1,657,729
+676,804
| +69% | +$4.55M | 0.07% | 341 |
|
|
2024
Q4 | $10.4M | Buy |
980,925
+56,533
| +6% | +$600K | 0.07% | 332 |
|
|
2024
Q3 | $13.5M | Buy |
924,392
+1,500
| +0.2% | +$21.9K | 0.11% | 242 |
|
|
2024
Q2 | $11.2M | Sell |
922,892
-395,164
| -30% | -$4.78M | 0.11% | 235 |
|
|
2024
Q1 | $32.5M | Buy |
1,318,056
+395,164
| +43% | +$9.75M | 0.3% | 100 |
|
|
2023
Q4 | $9.87M | Buy |
+922,892
| New | +$9.87M | 0.11% | 229 |
|